Statins as a newly recognized type of immunomodulator.

Kwak, Brenda; Mulhaupt, Flore; Myit, Samir; Mach, François

doi:10.1038/82219

Cited by 1,383Atherosclerosis and Cardiovascular DiseasesImmunotherapy and Immune ResponsesLipoproteins and Cardiovascular Health

Statins as a newly recognized type of immunomodulator.

Kwak, Brenda, Mulhaupt, Flore, Myit, Samir, Mach, François·2000·Nature Medicine

DOI 10.1038/82219

Open this paper in CoChat — free account

Abstract

Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, or statins, are effective lipid-lowering agents, extensively used in medical practice. Statins have never been shown to be involved in the immune response, although a report has indicated a better outcome of cardiac transplantation in patients under Pravastatin therapy. Major histocompatibility complex class II (MHC-II) molecules are directly involved in the activation of T lymphocytes and in the control of the immune response. Whereas only a limited number of specialized cell types express MHC-II constitutively, numerous other cells become MHC-II positive upon induction by interferon gamma (IFN-gamma). This complex regulation is under the control of the transactivator CIITA (refs 6,7). Here we show that statins act as direct inhibitors of induction of MHC-II expression by IFN-gamma and thus as repressors of MHC-II-mediated T-cell activation. This effect of statins is due to inhibition of the inducible promoter IV of the transactivator CIITA and is observed in several cell types, including primary human endothelial cells (ECs) and monocyte-macrophages (Mstraight phi). It is of note that this inhibition is specific for inducible MHC-II expression and does not concern constitutive expression of CIITA and MHC-II. In repressing induction of MHC-II, and subsequent T-lymphocyte activation, statins therefore provide a new type of immunomodulation. This unexpected effect provides a scientific rationale for using statins as immunosuppressors, not only in organ transplantation but in numerous other pathologies as well.

Integrity signals

Registry

Crossref · 10.1038/82219

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statins including atorvastatin repress the expression of MHC II molecules induced by IFN-γ, thereby impairing T-cell activation and compromising the adaptive immune response.
“It has also been shown that statins, including atorvastatin, repress the expression of MHC II molecules induced by IFN-γ, thereby impairing T-cell activation and compromising the adaptive immune response (Kwak et al., 2000).”
From Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice (2015) · cites this paper as Kwak et al., 2000

Effect of pravastatin on outcomes after cardiac transplantation
Kobashigawa, J. A., Katznelson, S., Laks, H., Johnson, J. A., Yeatman, L., Wang, X. M., Chia, D., Terasaki, P. I., Sabad, A., Cogert, G. A., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331003 · Cited by 1,301 · see citing works
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,217 · see citing works
Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., & Mach, B. (1994) · Science · doi:10.1126/science.8016643 · Cited by 898 · see citing works
Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
Steimle, V., Otten, L., Zufferey, M., & Mach, B. (1993) · Cell · doi:10.1016/s0092-8674(05)80090-x · Cited by 849 · see citing works
Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality: An Overview of Randomized Trials
Hebert, P. R. (1997) · JAMA · doi:10.1001/jama.1997.03550040069040 · Cited by 740 · see citing works
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosis
Mach, F., Schönbeck, U., Sukhova, G. K., Bourcier, T., Bonnefoy, J., Pober, J. S., & Libby, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1931 · Cited by 730 · see citing works
Self-citation
Statins do more than just lower cholesterol
Vaughan, C. J., Murphy, M. B., & Buckley, B. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05190-2 · Cited by 699 · see citing works
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 573 · see citing works
Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA
Mühlethaler‐Mottet, A., Otten, L., Steimle, V., & Mach, B. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2851 · Cited by 507 · see citing works
Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality
Hebert, P. R., Gaziano, J. M., Chan, K. S., & Hennekens, C. H. (1998) · Survey of Anesthesiology · doi:10.1097/00132586-199806000-00060 · Cited by 506 · see citing works
REGULATION OF MHC CLASS II GENES: Lessons from a Disease
Mach, B., Steimle, V., Martínez-Soria, E., & Reith, W. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.301 · Cited by 487 · see citing works
Activation of the MHC Class II Transactivator CIITA by Interferon-γ Requires Cooperative Interaction between Stat1 and USF-1
Mühlethaler‐Mottet, A., Berardino, W. D., Otten, L., & Mach, B. (1998) · Immunity · doi:10.1016/s1074-7613(00)80468-9 · Cited by 376 · see citing works
A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients
Masternak, K., Barras, E., Zufferey, M., Conrad, B., Corthals, G. L., Aebersold, R. H., Sanchez, J., Hochstrasser, D. F., Mach, B., & Reith, W. (1998) · Nature Genetics · doi:10.1038/3081 · Cited by 275 · see citing works
Stat1 α expression is involved in IFN-γ induction of the class II transactivator and class II MHC genes
Lee, Y. J., & Benveniste, E. N. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1559 · Cited by 124 · see citing works
Long-Term Culture of Human CD34+ Progenitors With FLT3-Ligand, Thrombopoietin, and Stem Cell Factor Induces Extensive Amplification of a CD34−CD14− and a CD34−CD14+ Dendritic Cell Precursor
Arrighi, J.-F., Hauser, C., Chapuis, B., Zubler, R. H., & Kindler, V. (1999) · Blood · doi:10.1182/blood.v93.7.2244 · Cited by 99 · see citing works
Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection
Petschner, F., Zimmermann, C., Strasser, A., Grillot, D., Núñez, G., & Pircher, H. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02 · Cited by 77 · see citing works
Statin trials and goals of cholesterol-lowering therapy after AMI
Pedersen, T. R. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70340-6 · Cited by 24 · see citing works
The Alloreactive and Self-Restricted CD4+ T Cell Response Directed Against a Single MHC Class II/Peptide Combination
Kovalik, J., Singh, N., Mendiratta, S. K., Martin, W. D., Ignatowicz, L., & Kaer, L. V. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1285 · Cited by 14 · see citing works

Flagged first, then by citations

Sorted by citations

Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773 · see citing works
The immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature reviews. Immunology · doi:10.1038/nri1882 · Cited by 2,176 · see citing works
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994 · see citing works
Cancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193 · see citing works
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701 · see citing works
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
Costanzo, M. R., Costanzo, M. R., Dipchand, A. I., Starling, R. C., Anderson, A. S., Chan, M. C. Y., Desai, S., Fedson, S., Fisher, P. W., Gonzales-Stawinski, G. V., et al. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.05.034 · Cited by 1,647 · see citing works
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,272 · see citing works
Immune mechanisms in atherosclerosis.
Hansson, G. K., Jonasson, L., Seifert, P. S., & Stemme, S. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.5.567 · Cited by 1,169 · see citing works
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,098 · see citing works
INFLAMMATION AND ATHEROSCLEROSIS
Hansson, G. K., Robertson, A.-K. L., & Söderberg‐Nauclér, C. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,049 · see citing works
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
Weitz‐Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J. A., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041 · see citing works
Beneficial Cardiovascular Pleiotropic Effects of Statins
Davignon, J. (2004) · Circulation · doi:10.1161/01.cir.0000131517.20177.5a · Cited by 955 · see citing works
Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Jain, M. K., & Ridker, P. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1901 · Cited by 916 · see citing works
Immune Mechanisms in Atherosclerosis
Hansson, G. K. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.100220 · Cited by 873 · see citing works
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
McCarey, D. W., McInnes, I. B., Madhok, R., Hampson, R., Scherbakova, O., Ford, I., Capell, H. A., & Sattar, N. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16449-0 · Cited by 818 · see citing works
Is obesity an inflammatory condition?
Das, U. N. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00672-4 · Cited by 799 · see citing works
Novel Clinical Markers of Vascular Wall Inflammation
Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754 · see citing works
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
Newman, C. B., Preiss, D., Tobert, J. A., Jacobson, T. A., Page, R. L., II, Goldstein, L. B., Chin, C. C., Tannock, L. R., Miller, M. J., Raghuveer, G., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atv.0000000000000073 · Cited by 760 · see citing works
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation
Greenwood, J., Steinman, L., & Zamvil, S. S. (2006) · Nature reviews. Immunology · doi:10.1038/nri1839 · Cited by 685 · see citing works
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 662 · see citing works
LXR signaling couples sterol metabolism to proliferation in the acquired immune response
Bensinger, S. J., Bradley, M. N., Joseph, S. B., Zelcer, N., Janssen, E. M., Hausner, M. A., Shih, R., Parks, J. S., Edwards, P. A., Jamieson, B. D., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.052 · Cited by 711 · see citing works
Mevalonate pathway: A review of clinical and therapeutical implications
Buhaescu, I., & Izzedine, H. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.03.016 · Cited by 620 · see citing works
Age-related inflammatory cytokines and disease
Brüünsgaard, H., & Pedersen, B. K. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00056-5 · Cited by 608 · see citing works
Sepsis and the Heart
Merx, M. W., & Weber, C. (2007) · Circulation · doi:10.1161/circulationaha.106.678359 · Cited by 603 · see citing works
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Wang, C., Liu, P., & Liao, J. K. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.11.004 · Cited by 593 · see citing works
Genetic Control of MHC Class II Expression
Ting, J. P.-Y., & Trowsdale, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00696-7 · Cited by 583 · see citing works
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
Wong, W. W.-L., Dimitroulakos, J., Minden, M., & Penn, L. Z. (2002) · Leukemia · doi:10.1038/sj.leu.2402476 · Cited by 579 · see citing works
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554 · see citing works
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives -
Zhou, Q., & Liao, J. K. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0110 · Cited by 567 · see citing works
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 546 · see citing works
Statin effects beyond lipid lowering—are they clinically relevant?
Bonetti, P. O. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00419-0 · Cited by 526 · see citing works
Inflammation, Immunity, and HMG-CoA Reductase Inhibitors
Schönbeck, U., & Libby, P. (2004) · Circulation · doi:10.1161/01.cir.0000129505.34151.23 · Cited by 499 · see citing works
Endothelial dysfunction: a comprehensive appraisal.
Esper, R. J., Nordaby, R. A., Vilariño, J. O., Paragano, A. J., Cacharrón, J. L., & Machado, R. A. (2006) · Cardiovascular Diabetology · doi:10.1186/1475-2840-5-4 · Cited by 493 · see citing works
Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes
Heeschen, C., Hamm, C. W., Laufs, U., Snapinn, S. M., Böhm, M., & White, H. D. (2002) · Circulation · doi:10.1161/01.cir.0000012530.68333.c8 · Cited by 480 · see citing works
Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis
Khatana, C., Saini, N. K., Chakrabarti, S., Saini, V., Sharma, A. K., Saini, R. V., & Saini, A. K. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5245308 · Cited by 481 · see citing works
Regulation of MHC class II gene expression by the class II transactivator
Reith, W., LeibundGut‐Landmann, S., & Waldburger, J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1708 · Cited by 463 · see citing works
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Gazzerro, P., Proto, M., Gangemi, G., Malfitano, A. M., Ciaglia, E., Pisanti, S., Santoro, A., Laezza, C., & Bifulco, M. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004994 · Cited by 458 · see citing works
A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation
Duivenvoorden, R., Tang, J., Cormode, D. P., Mieszawska, A. J., Izquierdo‐Garcia, D., Ozcan, C., Otten, M. J., Zaidi, N., Lobatto, M. E., van Rijs, S. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4065 · Cited by 442 · see citing works
A novel anti-inflammatory role for simvastatin in inflammatory arthritis.
Leung, B. P., Sattar, N., Crilly, A., Prach, M., McCarey, D. W., Payne, H., Madhok, R., Campbell, C., Gracie, J. A., Liew, F. Y., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1524 · Cited by 434 · see citing works
The Transcription Factor STAT-1 Couples Macrophage Synthesis of 25-Hydroxycholesterol to the Interferon Antiviral Response
Blanc, M., Hsieh, W. Y., Robertson, K. A., Kropp, K. A., Forster, T., Shui, G., Lacaze, P. A., Watterson, S., Griffiths, S. J., Spann, N. J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.11.004 · Cited by 413 · see citing works
Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?
Robinson, J. G., Smith, B., Maheshwari, N., & Schrott, H. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.085 · Cited by 407 · see citing works
Prior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis
Almog, Y., Shefer, A., Novack, V., Maimon, N., Barski, L., Eizinger, M., Friger, M. D., Zeller, L., & Danon, A. (2004) · Circulation · doi:10.1161/01.cir.0000138932.17956.f1 · Cited by 403 · see citing works
Drug-induced liver injury: Interactions between drug properties and host factors
Chen, M., Suzuki, A., Borlak, J. T., Andrade, R. J., & Lucena, M. I. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.016 · Cited by 404 · see citing works
Antioxidants Inhibit Nuclear Export of Telomerase Reverse Transcriptase and Delay Replicative Senescence of Endothelial Cells
Haendeler, J., Hoffmann, J., Diehl, J. F., Vasa‐Nicotera, M., Spyridopoulos, I., Zeiher, A. M., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000121104.05977.f3 · Cited by 382 · see citing works
Statins as anti-inflammatory agents
Weitz‐Schmidt, G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02077-1 · Cited by 354 · see citing works
Inflammatory Cytokines in Heart Failure: Mediators and Markers
Gullestad, L. L., Ueland, T., Vinge, L. E., Finsen, A. V., Yndestad, A., & Aukrust, P. (2012) · Cardiology · doi:10.1159/000338166 · Cited by 350 · see citing works
Anti-inflammatory and immunomodulatory effects of statins
Blanco‐Colio, L. M., Tuñón, J., Martı́n-Ventura, J. L., & Egido, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00744.x · Cited by 346 · see citing works
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction
Swanberg, M., Lidman, O., Padyukov, L., Eriksson, P. O., Åkesson, E., Jagodic, M., Lobell, A., Khademi, M., Börjesson, O., Lindgren, C. M., et al. (2005) · Nature Genetics · doi:10.1038/ng1544 · Cited by 339 · see citing works
High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles
Kuai, R., Li, D., Chen, Y. E., Moon, J. J., & Schwendeman, A. A. (2016) · ACS Nano · doi:10.1021/acsnano.5b07522 · Cited by 341 · see citing works
Sarcoidosis
Iannuzzi, M. C. (2011) · JAMA · doi:10.1001/jama.2011.10 · Cited by 334 · see citing works
A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma.
McKay, A., Leung, B. P., McInnes, I. B., Thomson, N. C., & Liew, F. Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2903 · Cited by 309 · see citing works
Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans
Morris, T., Stables, M. J., Hobbs, A. J., de Souza, P., Colville‐Nash, P., Warner, T. D., Newson, J., Bellingan, G. J., & Gilroy, D. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900477 · Cited by 322 · see citing works
Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation.
Parihar, S. P., Guler, R., Khutlang, R., Lang, D. M., Hurdayal, R., Mhlanga, M., Suzuki, H., Marais, A. D., & Brombacher, F. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jit550 · Cited by 295 · see citing works
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study
Aronow, H. D., Topol, E. J., Roe, M. T., Houghtaling, P. L., Wolski, K. E., Lincoff, A. M., Harrington, R. A., Califf, R. M., Ohman, E. M., Kleiman, N. S., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04257-4 · Cited by 308 · see citing works
Dementia of Alzheimer’s disease and other neurodegenerative disorders—memantine, a new hope
Sonkusare, S. K., Kaul, C. L., & Ramarao, P. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.05.005 · Cited by 306 · see citing works
Effects of Statins on 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition Beyond Low-Density Lipoprotein Cholesterol
Liao, J. K. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.009 · Cited by 303 · see citing works
Reduction in C-reactive protein through cardiac rehabilitation and exercise training
Milani, R. V., Lavie, C. J., & Mehra, M. R. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.041 · Cited by 302 · see citing works
Adaptive immunity and atherosclerosis
Andersson, J., Libby, P., & Hansson, G. K. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.07.002 · Cited by 292 · see citing works
Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Zhou, Q., & Liao, J. K. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315684 · Cited by 294 · see citing works
Statins Inhibit HIV-1 Infection by Down-regulating Rho Activity
del Real, G., Jiménez-Baranda, S., Mira, E., Lacalle, R. A., Lucas, P., Gómez‐Moutón, C., Alegret, M., Peña, J. M., Zapata, M. R., Álvarez‐Mon, M., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040061 · Cited by 294 · see citing works
Statin treatment after onset of sepsis in a murine model improves survival.
Merx, M. W., Liehn, E. A., Graf, J., van de Sandt, A., Schaltenbrand, M., Schrader, J., Hanrath, P., & Weber, C. (2005) · Circulation · doi:10.1161/circulationaha.104.502195 · Cited by 287 · see citing works
The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis
Blum, A., & Shamburek, R. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.022 · Cited by 287 · see citing works
Treatment of Relapsing Paralysis in Experimental Encephalomyelitis by Targeting Th1 Cells through Atorvastatin
Aktaş, O., Waiczies, S., Тихоновна, С. А., Dörr, J. R., Seeger, B., Prozorovski, T., Sallach, S., Endres, M., Brocke, S., Nitsch, R., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021425 · Cited by 282 · see citing works
Mini‐review: Specificity and expression of CIITA, the master regulator of MHC class II genes
LeibundGut‐Landmann, S., Waldburger, J., Krawczyk, M., Otten, L., Suter, T. B., Fontana, A., Acha‐Orbea, H., & Reith, W. (2004) · European Journal of Immunology · doi:10.1002/eji.200424964 · Cited by 277 · see citing works
Design of effective immunotherapy for human autoimmunity
Feldmann, M., & Steinman, L. (2005) · Nature · doi:10.1038/nature03727 · Cited by 277 · see citing works
HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis
Merx, M. W., Liehn, E. A., Janssens, U., Lütticken, R., Schrader, J., Hanrath, P., & Weber, C. (2004) · Circulation · doi:10.1161/01.cir.0000129774.09737.5b · Cited by 277 · see citing works
Blood–brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis
Floris, S., Blezer, E. L. A., Schreibelt, G., Döpp, E. A., van der Pol, S. M. A., Eestermans, I. L., Nicolay, K., Dijkstra, C. D., & de Vries, H. E. (2004) · Brain · doi:10.1093/brain/awh068 · Cited by 272 · see citing works
Statins and sepsis: multiple modifications at multiple levels
Terblanche, M., Almog, Y., Rosenson, R. S., Smith, T. S., & Hackam, D. G. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70111-1 · Cited by 271 · see citing works
NO and angiogenesis
Cooke, J. P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00034-5 · Cited by 266 · see citing works
5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranoside Inhibits Proinflammatory Response in Glial Cells: A Possible Role of AMP-Activated Protein Kinase
Giri, S., Nath, N., Smith, B., Viollet, B., Singh, A. K., & Singh, I. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4288-03.2004 · Cited by 266 · see citing works
Statins and the vascular endothelial inflammatory response
Greenwood, J., & Mason, J. C. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.12.003 · Cited by 263 · see citing works
The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery
Xia, Y., Xie, Y., Yu, Z., Xiao, H., Jiang, G., Zhou, X., Yang, Y., Li, X., Zhao, M., Li, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.070 · Cited by 256 · see citing works
Progressive myopathy with up-regulation of MHC-I associated with statin therapy
Needham, M., Fabian, V. A., Knezevic, W., Panegyres, P. K., Zilko, P. J., & Mastaglia, F. L. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.10.007 · Cited by 251 · see citing works
Simvastatin Rescues Rats From Fatal Pulmonary Hypertension by Inducing Apoptosis of Neointimal Smooth Muscle Cells
Nishimura, T., Vaszar, L. T., Faul, J. L., Zhao, G., Berry, G. J., Shi, L., Qiu, D., Benson, G. V., Pearl, R. G., & Kao, P. N. (2003) · Circulation · doi:10.1161/01.cir.0000087592.47401.37 · Cited by 250 · see citing works
Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells
Cafforio, P., Dammacco, F., Gernone, A., & Silvestris, F. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi036 · Cited by 250 · see citing works
Statins Reduce Interleukin-6–Induced C-Reactive Protein in Human Hepatocytes: New Evidence for Direct Antiinflammatory Effects of Statins
Arnaud, C., Burger, F., Steffens, S., Veillard, N. R., Nguyen, T. H., Trono, D., & Mach, F. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000163840.63685.0c · Cited by 247 · see citing works
Self-citation
Simvastatin Initiated Early After Heart Transplantation
Wenke, K., Meiser, B., Thiery, J., Nagel, D., von Scheidt, W., Krobot, K. J., Steinbeck, G., Seidel, D., & Reichart, B. (2003) · Circulation · doi:10.1161/01.cir.0000043241.32523.ee · Cited by 247 · see citing works
Effect of Statin Use Within the First 24 Hours of Admission for Acute Myocardial Infarction on Early Morbidity and Mortality††A complete list of participating hospitals is available from ClinTrials Research, 1100 Weston Parkway, Cary, North Carolina 27513.
Fonarow, G. C., Wright, R. S., Spencer, F. A., Fredrick, P. D., Dong, W., Every, N. R., & French, W. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.04.029 · Cited by 245 · see citing works
The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins
Hewitt, R. E., Lissina, A., Green, A. E., Slay, E. S., Price, D. A., & Sewell, A. K. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02665.x · Cited by 241 · see citing works
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients
Wakkee, M., Thio, H. B., Prens, E. P., Sijbrands, E. J. G., & Neumann, H. A. M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.07.011 · Cited by 239 · see citing works
High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery
Billings, F. T., Hendricks, P. A., Schildcrout, J. S., Shi, Y., Petracek, M. R., Byrne, J. G., & Brown, N. J. (2016) · JAMA · doi:10.1001/jama.2016.0548 · Cited by 237 · see citing works
Statins for the Prevention and Treatment of Infections
Tleyjeh, I. M. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.286 · Cited by 236 · see citing works
Anti-Angiogenic and Anti-Inflammatory Effects of Statins: Relevance to Anti-Cancer Therapy
Dulak, J., & Józkowicz, A. (2005) · Current Cancer Drug Targets · doi:10.2174/156800905774932824 · Cited by 235 · see citing works
Arterial calcification: A review of mechanisms, animal models, and the prospects for therapy
Wallin, R., Wajih, N., Greenwood, G. T., & Sane, D. C. (2001) · Medicinal Research Reviews · doi:10.1002/med.1010 · Cited by 232 · see citing works
The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells
Mausner-Fainberg, K., Luboshits, G., Mor, A., Maysel-Auslender, S., Rubinstein, A., Keren, G., & George, J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.031 · Cited by 233 · see citing works
A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation
Khatri, P., Roedder, S., Kimura, N., Vusser, K. D., Morgan, A. A., Gong, Y., Fischbein, M. P., Robbins, R. C., Naesens, M., Butte, A. J., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20122709 · Cited by 232 · see citing works
Statins Augment Vascular Endothelial Growth Factor Expression in Osteoblastic Cells via Inhibition of Protein Prenylation
Maeda, T., Kawane, T., & Horiuchi, N. (2003) · Endocrinology · doi:10.1210/en.2002-220682 · Cited by 230 · see citing works
Lovastatin inhibits brain endothelial cell Rho‐mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis
Greenwood, J., Walters, C. E., Pryce, G., Kanuga, N., Bemud, E., Baker, D., & Adamson, P. (2003) · The FASEB Journal · doi:10.1096/fj.02-1014fje · Cited by 227 · see citing works
Hegemony of inflammation in atherosclerosis and coronary artery disease
Attiq, A., Afzal, S., Ahmad, W., & Kandeel, M. K. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176338 · Cited by 228 · see citing works
Inflammatory markers and cardiovascular health in older adults
Kritchevsky, S. B., Cesari, M., & Pahor, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.026 · Cited by 222 · see citing works
Increased frequency of DRB1*11:01 in anti–hydroxymethylglutaryl‐coenzyme A reductase–associated autoimmune myopathy
Mammen, A. L., Gaudet, D., Brisson, D., Christopher‐Stine, L., Lloyd, T. E., Leffell, M. S., & Zachary, A. A. (2012) · Arthritis Care & Research · doi:10.1002/acr.21671 · Cited by 222 · see citing works
How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?
Li, L., Chen, X., Wang, W. E., & Zeng, C. (2015) · Stem Cells International · doi:10.1155/2016/9682757 · Cited by 221 · see citing works
Update on Statins: 2003
Vaughan, C. J., & Gotto, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000139312.10076.ba · Cited by 218 · see citing works
Lovastatin Enhances Clearance of Apoptotic Cells (Efferocytosis) with Implications for Chronic Obstructive Pulmonary Disease
Morimoto, K., Janssen, W. J., Fessler, M. B., McPhillips, K. A., Borges, V. M., Bowler, R. P., Xiao, Y., Kench, J. A., Henson, P. M., & Vandivier, R. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7657 · Cited by 215 · see citing works
Statins as immunomodulators
Neuhaus, O., Strasser‐Fuchs, S., Fazekas, F., Kieseier, B., Niederwieser, G., Hartung, H. ‐., & Archelos, J. J. (2002) · Neurology · doi:10.1212/wnl.59.7.990 · Cited by 215 · see citing works
Neuroprotective effects of atorvastatin against glutamate‐induced excitotoxicity in primary cortical neurones
Bösel, J., Gandor, F., Harms, C., Synowitz, M., Harms, U., Djoufack, P. C., Megow, D., Dirnagl, U., Hörtnagl, H., Fink, K., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02980.x · Cited by 210 · see citing works
T Lymphocyte–Endothelial Interactions: Emerging Understanding of Trafficking and Antigen-Specific Immunity
Carman, C. V., & Martinelli, R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00603 · Cited by 208 · see citing works
Antioxidant Effects of Statins via S -Nitrosylation and Activation of Thioredoxin in Endothelial Cells
Haendeler, J., Hoffmann, J., Zeiher, A. M., & Dimmeler, S. (2004) · Circulation · doi:10.1161/01.cir.0000138743.09012.93 · Cited by 206 · see citing works
Antiviral drug discovery: broad-spectrum drugs from nature
Martínez, J. P., Sasse, F., Brönstrup, M., Díez, J., & Meyerhans, A. (2014) · Natural Product Reports · doi:10.1039/c4np00085d · Cited by 199 · see citing works
Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes
Zhang, X., Jin, J., Peng, X., Ramgolam, V. S., & Markovic‐Plese, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6988 · Cited by 201 · see citing works

Authors: Kwak, B., Mulhaupt, F., Myit, S., & Mach, F.
Affiliations: University Hospital of Geneva (CH)
Corresponding author: Mach, François
ORCID: Kwak, Brenda
Mach, François
Venue: Nature Medicine
Publisher: Springer Science and Business Media LLC
Published: 2000-12
Volume: 6
Issue: 12
Pages: 1399-1402
ISSN: 1078-8956 (ISSN-L)
1546-170X
DOI: 10.1038/82219
OpenAlex: W1525331105
Cited by: 1,383
References: 18
Citations by year: 2026: 14 · 2025: 18 · 2024: 26 · 2023: 27 · 2022: 25 · 2021: 33 · 2020: 33 · 2019: 35 · 2018: 29 · 2017: 39 · 2016: 37 · 2015: 53 · 2014: 55 · 2013: 44 · 2012: 56
FWCI: 23.50
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (unspecified)
Locations: Nature Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords: statins, immunomodulation, MHC class II induction, interferon-gamma, CIITA, T cell activation, endothelial cells, monocytes/macrophages, immunosuppression, organ transplantation, pravastatin
MeSH terms: Atorvastatin, Adjuvants, Immunologic, Anticholesteremic Agents, Endothelium, Vascular, Genes, MHC Class II, Heptanoic Acids, Humans, Interferon-gamma, Lovastatin, Lymphocyte Activation, Macrophages, Monocytes, Nuclear Proteins, Pyrroles, Saphenous Vein, T-Lymphocytes, Trans-Activators, Pravastatin, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Statins as a newly recognized type of immunomodulator.

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks